Abstract
Myxobacteria, a group of antimicrobial producing bacteria, have been successfully cultured and characterized from ten soil samples collected from different parts of Slovakia. A total of 79 myxobacteria belonging to four genera (Myxococcus, Corallococcus, Sorangium, and Polyangium) were isolated based on aspects of their life cycle. Twenty-five of them were purified, fermented, and screened for antimicrobial activities against 11 test microorganisms. Results indicated that crude extracts showed more significant activities against Gram-positive than against Gram-negative bacteria or fungi. Based on a higher degree and broader range of antimicrobial production, the two most potential extracts (K9-5, V3-1) were selected for HPLC fractionation against Micrococcus luteus and Staphylococcus aureus and LC/MS analysis of potential antibiotic metabolites. The analysis resulted in the identification of polyketide-peptide antibiotics, namely corallopyronin A and B (K9-5) and myxalamid B and C (V3-1), which were responsible for important Gram-positive activity in the observed strains. A sequence similarity search through BLAST revealed that these strains showed the highest sequence similarity to Corallococcus coralloides (K9-5, NCBI accession number KX256198) and Myxococcus xanthus (V3-1, NCBI accession number KX256197). Although screening of myxobacteria is laborious, due to difficulties in isolating cultures, this research represented the first report covering the isolation and cultivation of this challenging bacterial group from Slovakian soils as well as the screening of their antimicrobial activity, cultural identification, and secondary metabolite identification.
Similar content being viewed by others
References
Ahn J, Li XM, Zee O (2007) Soraphinol B, a new acyloin compound produced by Sorangium cellulosum. Bull Kor Chem Soc 28:1215–1216. doi:10.1002/chin.200749208
Belogurov GA, Vassylyeva MN, Sevostyanova A, Appleman JR, Xiang AX, Lira R, Webber SE, Klyuyev S, Nudler E, Artsimovitch I, Vassylyev DG (2009) Transcription inactivation through local refolding of the RNA polymerase structure. Nature 457:332–335. doi:10.1038/nature07510
Berleman JE, Kirby JR (2009) Deciphering the hunting strategy of a bacterial wolfpack. FEMS Microbiol Rev 33:942–957. doi:10.1111/j.1574-6976.2009.00185.x
Bode HB, Müller R (2006) Analysis of myxobacterial secondary metabolism goes molecular. J Ind Microbiol 33:577–588. doi:10.1007/s10295-006-0082-7
Cane DE (1997) Polyketide and nonribosomal polypeptide biosynthesis. Chem Rev 97:2463–2706. doi:10.1021/cr970097g
Cazin J, Wiemer DF, Howard JJ (1989) Isolation, growth characteristics, and long-term storage of fungi cultivated by attine ants. App Environ Microbiol 55:1346–1350
Dawid W (2000) Biology and global distribution of myxobacteria in soils. FEMS Microbiol Rev 24:403–427. doi:10.1111/j.1574-6976.2000.tb00548.x
Erol O, Schaberle TF, Schmitz A, Konig GM (2010) Biosynthesis of the myxobacterial antibiotic corallopyronin A. Chembiochem 11:1253–1265. doi:10.1002/cbic.201000085
Felsenstein J (1981) Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17:368–376. doi:10.1007/bf01734359
Gaspari F, Paitan Y, Mainini M, Losi D, Ron EZ, Marinelli F (2005) Myxobacteria isolated in Israel as potential source of new anti-infectives. J Appl Microbiol 98:429–439. doi:10.1111/j.1365-2672.2004.02477.x
Gebreyohannes G, Moges F, Sahile S, Raja N (2013) Isolation and characterization of potential antibiotic producing actinomycetes from water and sediments of lake Tana, Ethiopia. Asian Pac J Trop Biomed 3:426–435. doi:10.1016/s2221-1691(13)60092-1
Gerth K, Jansen R, Reifenstahl G, Thierbach G (1983) The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action. J Antibiot 36:1150–1156. doi:10.7164/antibiotics.36.1150
Gerth K, Trowitzsch W, Piehl G, Schultze R, Lehmann J (1984) Inexpensive media for mass cultivation of myxobacteria. Appl Microbiol Biotechnol 19:23–28. doi:10.1007/bf00252812
Gerth K, Pradella S, Perlova O, Beyer S, Müller R (2003) Myxobacteria: proficient producers of novel natural products with various biological activities—past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol 106:233–253. doi:10.1016/j.jbiotec.2003.07.015
Irschik H, Jansen R, Hofle G, Gerth K, Reichenbach H (1985) The corallopyronins, new inhibitors of bacterial RNA synthesis from myxobacteria. I Antibiot 38:145–152. doi:10.7164/antibiotics.38.145
Jansen R, Irschik H, Reichenbach H, Höfle G (1985) Corallopyronin A, B, and C: three novel antibiotics from Corallocuccus coralloides Cc c127 (Myxobacterales). Liebigs Ann Chem 4:822–836. doi:10.1002/chin.198533371
Lane DJ (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow (eds) Nucleic acid techniques in bacterial systematics. Wiley, UK, pp 115–176
Lang E, Stackebrandt E (2009) Emended descriptions of the genera Myxococcus and Corallococcus, typification of the species Myxococcus stipitatus and Myxococcus macrosporus and a proposal that they be represented by neotype strains. Request for an opinion. Int J Syst Evol Microbiol 59:2122–2128. doi:10.1099/ijs.0.003566-0
McBride MJ, Zusman DR (1996) Behavioral analysis of single cells of Myxococcus xanthus in response to prey cells of Escherichia coli. FEMS Microbiol Lett 137:227–231. doi:10.1111/j.1574-6968.1996.tb08110.x
Mohr KI, Stechling M, Wink J, Wilharm E, Stadler M (2015) Comparison of myxobacterial diversity and evaluation of isolation success in two niches: Kiritimati Island and German compost. Microbiol open 5:268–278. doi:10.1002/mbo3.325
Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R, Irschik H, Arnold E, Ebright RH (2008) The RNA polymerase “switch region” is a target for inhibitors. Cell 135:295–307. doi:10.3410/f.1157302.617440
O’Neill A, Oliva B, Storey C, Hoyle A, Fishwick C, Chopra I (2000) RNA polymerase inhibitors with activity against rifampicin-resistant mutants of Staphylococcus aureus. Antimicrob Ag Chemother 44:3163–3166. doi:10.1128/aac.44.11.3163-3166.2000
Reichenbach H (1986) The myxobateria: common organisms with uncommon behaviour. Microbiol Sc 3:268–274
Reichenbach H (1993) Biology of the myxobacteria: ecology and taxonomy. In: Dworkin M, Kaiser D (eds) Myxobacteria II. ASM Press, Washington DC, pp 13–62
Reichenbach H (2001) Myxobacteria producers of novel bioactive substances. J Ind Microbiol Biotechnol 27:1057–1098. doi:10.1038/sj.jim.7000025
Reichenbach H (2005) Genus II. Corallococcus gen. Nov. (Chondrococcus Jahn 1924, 85). In: Brenner DJ, Krieg NR, Staley JT, Garrity GM (eds) Bergey's manual of systematic bacteriology. Springer, New York, pp 1079–1082
Reichenbach H, Dworkin M (1992) The myxobacteria. In: Balows A, Truper HG, Dworkin M, Harder W, Schleifer KH (eds) The prokaryotes. Springer, New York, pp 3417–3487
Shimkets L, Dworkin M, Reichenbach H (2006) The myxobacteria. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackenbrandt E (eds) The prokaryotes. Springer, New York, pp 31–115
Schäberle TF, Mohseni MM, Lohr F, Schmitz A, König GM (2014) Function of the loading module in CorI and of the O-methyltransferase CorH in vinyl carbamate biosynthesis of the antibiotic corallopyronin A. Antimicrob Agents Chemother 58:950–956. doi:10.1128/aac.01894-13
Silakowski B, Nordsiek G, Kunze B, Blöcker H, Müller R (2001) Novel features in a combined polyketide synthase/non-ribosomall peptide synthetase: the myxalamid biosynthetic gene cluster of the myxobacterium Stigmatella aurantiaca Sga 15. Chem Biol 8:59–69. doi:10.1016/s1074-5521(00)00056-9
Silakowski B, Schairer HU, Ehret H, Kunze B, Weinig S, Nordsiek G, Brandt P, Blöcker H, Höfle G, Beyer S, Müller R (1999) New lessons for combinatorial biosynthesis from myxobacteria: the myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J Biol Chem 274:37391–37399. doi:10.1074/jbc.274.52.37391
Spröer C, Reichenbach H, Stackebrandt E (1999) The correlation between morphogenetic classification of myxobacteria. Int J Syst Bacteriol 4:1255–1262. doi:10.1099/00207713-49-3-1255
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–2729. doi:10.1093/molbev/mst197
Weissman KJ, Muller R (2010) Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat Prod Rep 27:1276–1295. doi:10.1002/chin.201051263
Wenzel SC, Muller R (2009) Myxobacteria-microbial factories for the production of bioactive secondary metabolites. Mol BioSyst 5:567–574. doi:10.1039/b901287g
Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163–175. doi:10.1038/nprot.2007.521
Zhang X, Yao Q, Cai Z, Xie X, Zhu H (2003) Isolation and identification of myxobacteria from saline-alkaline soils in Xinjiang, China. PLoS One 8:e70466. doi:10.1371/journal.pone.0070466
Acknowledgements
The author is grateful to the Helmholtz Centre for Infection Research (Microbial Strain Collection Group), Braunschweig, Germany, for the scholarship and supporting of the results. This study was also supported by the Europien Community under project no. 26220220180: Building Research Centre Agrobiotech.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Charousová, I., Steinmetz, H., Medo, J. et al. Soil myxobacteria as a potential source of polyketide-peptide substances. Folia Microbiol 62, 305–315 (2017). https://doi.org/10.1007/s12223-017-0502-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-017-0502-2